A new collaboration between UConn Health and the Foundation for Prader-Willi Research will create a centralized, high quality biobank of stem cells to help researchers better understand Prader-Willi syndrome, a rare genetic disease that may hold insights into obesity, developmental delays, autism spectrum disorders, and many other conditions.
The biobank plans to supply induced-pluripotent stem cells for Prader-Willi syndrome to researchers throughout Connecticut and the world.